Clinical Trial: A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536061) titled 'A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease' on April 10.

Brief Summary: This is a first-in-human, multi-center trial studying the effects of SRP-1005 in participants with Huntington's disease (HD).

Study Start Date: May 05

Study Type: INTERVENTIONAL

Condition: Huntington's Disease

Intervention: DRUG: SRP-1005

Subcutaneous injection

DRUG: Placebo

Subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sarepta Therapeutics, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....